Cake Recall Update as FDA Sets Highest Concern Level for Multiple Products
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A recall of numerous cake products due to potential salmonella contamination has been issued the highest risk warning by the U.S. Food and Drug Administration (FDA).
King Cheesecake Company, Inc., based in Texas, issued a voluntary recall for six products on July 18 as pecans contained with the cakes may have been contaminated. The FDA later issued a Class I risk classification for the recall on August 7.
Newsweek contacted King Cheesecake Company, Inc. for comment by email outside of regular working hours.
Stock image. King Cheesecake Company, Inc. issued a voluntary recall for six products on July 18 due to potential salmonella contamination.
Stock image. King Cheesecake Company, Inc. issued a voluntary recall for six products on July 18 due to potential salmonella contamination.
Silas Stein/picture-alliance/dpa/AP
Why It Matters
A Class I risk classification represents "a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death," according to the FDA.
Salmonella bacteria can cause gastrointestinal illness and fever called salmonellosis. Symptoms typically develop 12 to 72 hours after infection, and usually last between four and seven days.
Typical symptoms include diarrhea, fever and abdominal cramps. People experiencing more severe infections may also suffer high fever, aches, headaches, lethargy, rashes and blood in their urine.
Infections can become fatal on rare occasions, with about 450 people dying each year from salmonellosis, according to the FDA.
The infection is particularly dangerous for young children, frail or elderly people, and those with weakened immune systems.
What To Know
The products affected by the recall include the following:
Assorted Layer Cake
Italian Layer Cake
Carrot Layer Cake
Tres Leches Cheesecake
Hummingbird Layer Cake
Chocolate Tres Leches Cheesecake
The products were manufactured between June 20 and July 14. They were distributed to Alabama, Texas, Florida, Louisiana, Oklahoma and Illinois.
What People Are Saying
The Centers for Disease Control and Prevention's guidance on salmonella: "In some people, the illness may be so severe that the patient is hospitalized. Salmonella infection may spread from the intestines to the bloodstream and then to other parts of the body."
The FDA, on its website: "Children younger than five, the elderly, and people with weakened immune systems are more likely to have severe salmonellosis infections.
"Wash the inside walls and shelves of the refrigerator, cutting boards and countertops, and utensils that may have contacted contaminated foods; then sanitize them with a solution of one tablespoon of chlorine bleach to one gallon of hot water; dry with a clean cloth or paper towel that has not been previously used.
"People with pets should take special care to avoid cross-contamination when preparing their pet's food. Be sure to pick up and thoroughly wash food dishes as soon as pets are done eating, and prevent children, the elderly, and any other people with weak immune systems from handling or being exposed to the food or pets that have eaten potentially contaminated food."
What Happens Next
The recall is listed as ongoing, according to the FDA.
Consumers who purchased the affected products should not consume them.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
4 hours ago
- The Hill
FDA says IV saline shortage is over
A longtime shortage of a type of sterile intravenous saline is now resolved, the Food and Drug Administration announced Friday. According to the FDA, sodium chloride 0.9% injection products have been in shortage since 2018. The shortage was exacerbated when Hurricane Helene flooded a Baxter manufacturing plant in Marion, N.C. last fall what was responsible for 60 percent of the IV fluid in the country. 'This marks a significant milestone for public health and reinforces the FDA's commitment to ensuring Americans have consistent access to life-saving medical products,' FDA Commissioner Marty Makary said in a statement. Hospitals were left scrambling in the aftermath of Helene, as the shortage of multiple types IV fluid highlighted the fragility and vulnerability of the country's medical supply chain. Many were forced to curtail elective procedures and ration supplies. The IV fluid market is made up of primarily four manufacturers: Baxter International, which makes about 60 percent; B. Braun Medical, which makes about 23 percent; along with ICU Medical and Fresenius Kabi. It's common to see the same products go on and off the shortage list for years. Prior to Helene, certain IV solutions had been in shortage for almost 10 years. Experts have long warned about allowing critical supplies to be highly concentrated in one place. But manufacturing requirements for sterility mean a high barrier to entry into the market, and with low returns on investment for manufacturers, hospitals and suppliers have few options for recourse. The FDA said it is working closely with manufacturers and will continue to monitor the supply of other IV fluids, which are still in shortage. 'The availability of reliable medical products is essential to patient care and the overall resilience of our healthcare system. Addressing this shortage has been a top priority for the FDA,' Makary said.
Medscape
4 hours ago
- Medscape
FDA Approves Zongertinib for HER2-Mutated NSCLC
The FDA has granted accelerated approval to zongertinib (Hernexeos, Boehringer Ingelheim Pharmaceuticals, Inc.) for certain adults with unresectable or metastatic nonsquamous non-small cell lung cancer (NSCLC). Specifically, the TKI was approved for patients whose tumors harbor HER2 ( ERBB2 ) tyrosine kinase domain-activating mutations as detected by an FDA-approved test and who have received prior systemic therapy, according to the approval notice. The novel agent is the first orally administered, targeted therapy for previously treated patients with HER2 ( ERBB2 )-mutant NSCLC, who have poor prognosis and limited treatment options, Boehringer Ingelheim noted in a February 2025 press release announcing the agent having been granted priority review. Zongertinib had previously received breakthrough therapy and fast track designation. The FDA also approved the Oncomine DX Target Test (Life Technologies Corporation) to help detect the target mutations and identify patients who may be eligible for zongertinib treatment. 'With the approval of zongertinib, we have an effective, targeted, orally administered treatment option for patients with HER2 (ERBB2)-mutant non-small cell lung cancer in the U.S. that not only elicits a durable response but, importantly, has a manageable safety profile,' said John Heymach, MD, PhD, chair of thoracic/head and neck medical oncology at The University of Texas MD Anderson Cancer Center, Houston, and coordinating investigator for the Beamion-LUNG 1 trial, stated in a press release. 'In a patient population where there are currently limited treatment options, this approval represents a significant advancement in cancer care.' Zongertinib approval was based on efficacy demonstrated in the open-label phase 1b Beamion LUNG-1 dose escalation trial. Among 71 patients who had received prior platinum-based chemotherapy but who had not received a HER2-targeted TKI or antibody-drug conjugate, 75% had an objective response and 58% had duration of response of at least 6 months. Among 34 patients who had received both platinum-based chemotherapy and a HER2-targeted antibody-drug conjugate, the objective response and duration of response rates were 44% and 27%, respectively. Boehringer Ingelheim reported that dose reductions occurred in only 5% of patients, and only 2.9% discontinued treatment. Most treatment-related adverse events were manageable, with diarrhea, hepatotoxicity, and rash occurring most commonly. The prescribing information, which will be posted at Drugs@FDA, includes warnings and precautions for hepatotoxicity, left ventricular dysfunction, interstitial lung disease, and embryo-fetal toxicity. The recommended zongertinib dose is 120 mg given orally once daily for patients who weigh less than 90 kg and 180 mg given orally once daily for those who weigh 90 kg or greater. Zongertinib can be taken with or without food and can be continued until disease progression or unacceptable toxicity, according to the full prescribing information.
Newsweek
4 hours ago
- Newsweek
Scientists Reveal Secrets to Getting Your Cat to Love You
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. As independent creatures, cats often get a reputation that they are hard to win over, but scientists might have cracked the code to building a stronger bond. A study published in the Journal of Veterinary Behavior presented 413 participants with a questionnaire based on the Cat/Dog-Owner Relationship Scale, or C/DORS, which measures the quality of the bond between felines and their owners—the first of its kind conducted in Spain. Results found the quality of an owner-cat relationship is related to factors such as lifestyle, breed, time spent alone, type of housing, behavioral problems and the number of cats living together. Thirteen of the 22 variables affected the relationship between cats and humans, while nine did not. Owners, or future pet parents, should consider the following factors when wanting to strengthen their bond with their cats, according to the study. A stock image of a woman holding a gray and white cat in her arms. A stock image of a woman holding a gray and white cat in her arms. Olezzo/Getty Images The Study's Findings Understanding Signals Cats are deliberate with every move. They use their eyes, tails and meows to communicate. Owners who understand their cat's vocalizations and signals tend to report stronger bonds. Learning a cat's signals can help identify signs of pain, fear, stress and more. Purebred vs. Mixed Breeds The study found purebred cats have a more positive relationship than non-pedigree felines, also known as mixed breeds, due to their predictable behaviors from selective breeding practices and tracing their ancestry. They tend to be more interactive. However, mixed-breed cats are adaptable and low-maintenance. They are often considered more independent than purebreds. Acquisition of Cats Owners who adopted or picked up felines as strays resulted in a "superior level of owner-rated attachment" when compared to those who purchased cats. The authors believe this could be due to a strong emotional connection adopters feel. They take on a humanitarian responsibility. While those who purchase cats, usually from breeders or pet shops, generally seek a specific breed, age, size or temperament. Behavioral Issues A cat's behavior, when moderate or severe, can erode a bond with an owner. Problematic behaviors might include aggression, house soiling or activity throughout the night. The impact depends on how the owner perceives the behavior. Time Spent Together To strengthen the bond with your cat, consider the amount of time spent together. The study found that cats who are left alone for less than four hours have a higher-quality relationship with their humans. Home Impacts Based on the study's answers, cats who live in apartments have a higher quality relationship with their humans. This may be due to proximity, more shared space and frequent interaction—like sleeping in their owner's bed. Apartment-living cats also have a stronger bond because owners tend to purchase more toys, spend more time together, allow them to use household objects and even celebrate their birthdays. Multi-cat homes can also positively impact the relationship between them and their owners. Felines might feel less alone. Owners of more than one cat tend to be more invested, understanding their signals and communication. There tends to be more interaction and higher engagement. Owners should be aware of the potential anxiety and stress cats might experience when living with other pets. The study did not find a significant impact of indoor versus outdoor cats on the relationship between them and humans. Improving Bonds While the overall relationship between owners and cats from this population remained strong, with an average score of 78.78 out of 100 on relationship quality, there is always room for improvement. The study noted some factors, including a cat's breed, are unable to be changed once adopted or brought home. However, owners can increase bonding time, learn the way felines communicate and how to correctly deal with unwanted cat behaviors before they lead to a strain on the relationship.
